Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program-Reference-Cited by-同舟云学术

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

Published:2002-02 Issue:2 Volume:42 Page:137-139
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N,Della-Latta Phyllis,Lee Lillian V,Biedenbach Douglas J

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference12 articles.

1. Oxazolidinones;Diekema;Drug,2000

2. Susceptibility of a variety of clinical isolates to linezolid;Gemmell;Journal of Antimicrobiology and Chemotherapy,2001

3. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid;Gonzales;Lancet,2001

4. In vivo studies of novel oxazolidinones with O- and N-linked C-5 heterocyclic side-chains, including AZD2563;Gravestock,2001

5. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid;Henwood;Journal of Antimicrobiology and Chemotherapy,2000

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria;Clinical Microbiology Reviews;2021-06-16

2. Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016;Open Forum Infectious Diseases;2019-03

3. Nanomaterials as a Novel Class of Anti-infective Agents that Attenuate Bacterial Quorum Sensing;Antibacterial Drug Discovery to Combat MDR;2019

4. Novel Classes of Antibacterial Drugs in Clinical Development, a Hope in a Post-antibiotic Era;Current Topics in Medicinal Chemistry;2018-10-10

5. Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus;Open Forum Infectious Diseases;2018-10-01